Table 4 of Hou, Mol Vis 2008; 14:2597-2603.


Table 4. Stratification analysis for HLA-DR4 and SUMO4 polymorphisms and the comparison of frequencies of SUMO4 allele and genotype in HLA-DR4+ patients versus HLA-DR4+ controls and HLA-DR4- patients versus HLA-DR4- controls.



SNPs

Genotype
allele
HLA-DR4+
Patients
n=179 (%)
HLA-DR4+
Controls
n=59 (%)


p value


pca value
HLA-DR4-
Patients
n=52 (%)
HLA-DR4-
Controls
n=243 (%)


p value


pca value
−847 G→A GG 12 (6.8) 10 (17.2) 0.041 NSb 4 (8.0) 20(8.4) 0.757 NS
AG 81 (46.0) 20 (34.5)     23 (46.0) 96 (40.3)

AA 83 (47.2) 28 (48.3)     23 (46.0) 122 (51.3)

G 105 (29.8) 40 (34.5) 0.347 NS 31 (31.0) 136 (28.6) 0.627 NS
A 247 (70.2) 76 (65.5)     69 (69.0) 340 (71.4)

−504 A→G AA 40 (22.9) 11 (19.0) 0.656 NS 14 (28.0) 55 (23.0) 0.696 NS
AG 85 (48.6) 27 (46.6)     22 (44.0) 119 (49.8)

GG 50 (28.6) 20 (34.5)     14 (28.0) 65 (27.2)

A 165 (47.1) 49 (42.2) 0.359 NS 50 (50.0) 249 (52.1) 0.703 NS
G 185 (52.9) 67 (57.8)     50 (50.0) 229 (47.9)

+163 A→G AA 84 (46.9) 29 (49.2) 0.820 NS 23 (45.1) 116 (47.7) 0.872 NS
AG 83 (46.4) 25 (42.4)     24 (47.1) 105 (43.2)

GG 12 (6.7) 5 (8.5)     4 (7.8) 22 (9.1)

A 251 (70.1) 83 (70.3) 0.963 NS 70 (68.6) 337 (69.3) 0.887 NS
G 107 (29.9) 35 (29.7)     32 (31.4) 149 (30.7)

+438 C→T CC 82 (46.3) 29 (49.2) 0.089 NS 25 (48.1) 106 (43.6) 0.562 NS
CT 85 (48.0) 22 (37.3)     22 (42.3) 100 (41.2)

TT 10 (5.6) 8 (13.6)     5 (9.6) 37 (15.2)

C 249 (70.3) 80 (67.8) 0.603 NS 72 (69.2) 312 (64.2) 0.328 NS
T 105 (29.7) 38 (32.2)     32 (30.8) 174 (35.8)